Hiromi Sugimoto Selected Research

Hiromi Sugimoto Research Topics

2	Inflammation (Inflammations) 01/2018 - 07/2004
2	Eosinophilia 11/2003 - 04/2003
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Idiopathic Pulmonary Fibrosis 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018
1	Liver Neoplasms (Liver Cancer) 01/2018
1	Neoplasms (Cancer) 01/2018
1	Chronic Disease (Chronic Diseases) 12/2011
1	Pneumonia (Pneumonitis) 12/2011
1	Motor Disorders 05/2009
1	Hypersensitivity (Allergy) 02/2008
1	Osteosarcoma (Osteogenic Sarcoma) 12/2005
1	Pain (Aches) 12/2005
1	Atopic Dermatitis (Atopic Eczema) 07/2004
1	Contact Dermatitis (Eczema, Contact) 07/2004
1	Lymphoma (Lymphomas) 11/2003
1	Allergic Rhinitis 04/2003

2	pirfenidoneIBA 01/2020 - 01/2018
2	ProstaglandinsIBA 07/2004 - 04/2003
2	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 07/2004 - 11/2003
2	Prostaglandins DIBA 07/2004 - 04/2003
2	ramatrobanIBA 11/2003 - 04/2003
1	CytokinesIBA 01/2020
1	Hydroxyproline (4 Hydroxyproline)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2018
1	Extracellular Matrix ProteinsIBA 01/2018
1	CollagenIBA 01/2018
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2018
1	SmokeIBA 12/2011
1	4- ((4- ((((3- Isopropyl- 2- oxo- 2,3- dihydro- 1H- benzimidazol- 1- yl)carbonyl)amino)methyl)piperidin- 1- yl)methyl)tetrahydro- 2H- pyran- 4- carboxylic acidIBA 05/2009
1	Analgesics (Analgesic Drugs)IBA 02/2008
1	N- ((1S)- 1- (aminocarbonyl)- 2,2- dimethylpropyl)- 3- (3- hydroxy- 3- methylbutyl)- 2- oxo- 2,3- dihydro- 1H- benzimidazole- 1- carboxamideIBA 02/2008
1	CannabinoidsIBA 02/2008
1	LigandsIBA 02/2008
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 12/2005
1	Biological ProductsIBA 12/2005
1	Eicosanoid Receptors (Eicosanoid Receptor)IBA 12/2005
1	Cyclic AMP (AMP, Cyclic)IBA 12/2005
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 12/2005
1	Fluorescein-5-isothiocyanate (FITC)IBA 07/2004
1	Chemotactic FactorsIBA 07/2004
1	ChemokinesIBA 07/2004
1	CalciumIBA 11/2003
1	Prostaglandin H2 Thromboxane A2 ReceptorsIBA 11/2003
1	Prostaglandin D2IBA 11/2003
1	AntigensIBA 04/2003
1	ThromboxanesIBA 04/2003

1	Ligation 07/2004
1	Intranasal Administration 04/2003